Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qixleef for Uncontrolled Pain in Advanced Cancer
NCT04042545Phase 2Unknown
- Sponsor
- Tetra Bio-Pharma Inc.
- Start
- Jul 2020
- Primary completion
- Sep 2021
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 2 trial of qixleef in cancer pain, sponsored by Tetra Bio-Pharma Inc.. Status: unknown.
02
Drugs
qixleef
03
Conditions
cancer pain
Beyond the preview
Go deeper on NCT04042545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04042545.